T. Rowe Price Associates’s Zomedica Corp. ZOM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-948,300
| Closed | -$139K | – | 3088 |
|
|
2024
Q1 | $139K | Buy |
948,300
+276,100
| +41% | +$40.5K | ﹤0.01% | 2714 |
|
|
2023
Q4 | $135K | Buy |
672,200
+186,800
| +38% | +$37.5K | ﹤0.01% | 2655 |
|
|
2023
Q3 | $82K | Buy |
485,400
+153,400
| +46% | +$25.9K | ﹤0.01% | 2695 |
|
|
2023
Q2 | $67K | Hold |
332,000
| – | – | ﹤0.01% | 2761 |
|
|
2023
Q1 | $71K | Hold |
332,000
| – | – | ﹤0.01% | 2742 |
|
|
2022
Q4 | $54K | Buy |
332,000
+144,000
| +77% | +$23.4K | ﹤0.01% | 2805 |
|
|
2022
Q3 | $40K | Hold |
188,000
| – | – | ﹤0.01% | 2860 |
|
|
2022
Q2 | $41K | Hold |
188,000
| – | – | ﹤0.01% | 2874 |
|
|
2022
Q1 | $63K | Buy |
188,000
+71,900
| +62% | +$24.1K | ﹤0.01% | 2896 |
|
|
2021
Q4 | $36K | Sell |
116,100
-390,400
| -77% | -$121K | ﹤0.01% | 2941 |
|
|
2021
Q3 | $265K | Sell |
506,500
-126,100
| -20% | -$66K | ﹤0.01% | 2616 |
|
|
2021
Q2 | $527K | Buy |
632,600
+244,800
| +63% | +$204K | ﹤0.01% | 2366 |
|
|
2021
Q1 | $613K | Buy |
+387,800
| New | +$613K | ﹤0.01% | 2270 |
|